This site is intended for Healthcare professionals only.

ICMR develops Ayurvedic Capsule to Cure Dengue, currently under Trial


ICMR develops Ayurvedic Capsule to Cure Dengue, currently under Trial

Belagavi: Indian scientists associated with the Indian Council of Medical Research have created first of its kind of Ayurvedic medicine to cure Dengue, the fastest growing mosquito-borne disease in the world.

The medicine comes in the form of a new capsule that can control dengue fever and has been developed by the central government-owned Indian Council of Medical Research (ICMR) center in Belagavi, Karnataka. The capsule is a purely ayurvedic drug using herbs. Currently, the capsule is under testing and once the report is out, the Food and Drug control authority will take its final decision on the same.

According to Professor Vaidya KS Dhiman, Director General of CCRAS, the Double-Blind Placebo-Controlled Clinical Trial, which is a medical study involving human participants and is an internationally accepted method of testing is going on in the medical colleges of Belgaum and Kolar. This drug has been made with seven herbal ingredients which are in use in Ayurveda system of medicine for centuries, Dhiman said to Hindustan Times

Dhiman told the media that the researchers started working on making the drug in 2015 and in the process pilot studies were conducted which proved the clinical safety and efficacy of the drug in the management and treatment of dengue.

Before the capsule formula was put together, an Ayurvedic drink called Kashaya was researched and given to some patients. The drink was rejected because it was very sour and gave late results.

Director of ICMR, Mr. S.L.Hoti told the ET Healthworld, “The capsule has shown positive results and if the concerned authorities give permission, the capsule might be available for sale from October.

According to WHO, dengue is the fastest growing mosquito-borne disease in the world today, causing nearly 400 million infections every year. India in 2017 has seen 15, 7220 cases of dengue and 250 deaths due to the disease (till December 24), as per the National Vector Borne Disease Control Programme (NVBDCP) data. In 2016, the country registered 129166 cases and 245 deaths.

Dengue fever, also known as a break-bone fever, is an infectious tropical disease caused by the dengue virus. Symptoms include fever, headache, muscle and joint pains and a characteristic skin rash. In a small number of cases, the disease develops into the life-threatening dengue hemorrhagic fever, resulting in bleeding, low levels of blood platelets and plasma leakage or into dengue shock syndrome, where very low blood pressure occurs.

The following two tabs change content below.
Vinay Singh

Vinay Singh

Vinay Singh joined Medical Dialogue as Desk Editor in 2018. He covers the medical speciality news in different medical categories including Medical guidelines, updates from Medical Journals and Case Reports. He completed his graduation in Biotechnology from AAIDU and did his MBA from IILM Gurgaon. He can be contacted at editorial@medicaldialogues.in . Contact no. 011-43720751
Source: press release

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted
  1. user
    Dr Krishnadas sen May 22, 2018, 5:13 pm

    This seems an welcome development.

  2. Anything which is proved by trial is allopathy, modern medicine, irrespective of content, \’capsule \’ is used by modern medicine only.

  3. ICMR should first publish their results in an international journal after proper peer review. Just because it is Ayurvedic and since the current government is interested in this area does not mean one has to go round the rules and introduce an untested drug into the market. This reminds me of a NSAID introduced by IICT of Hyderabad in late 1980\’s as the best drug in the area of NSAIDs with all the cooked up data and after introduction into the market they withdrew it since it was not working. In India even scientists cook up date to satisfy the politicians. This drug first should be given to politicians for testing, if possible!

  4. What is dengue fever and this so called formulation works at what level of the disease . Dengue is a self limiting disease and only complication should be treated . With out knowing the pathophysiology of the disease and how and at what level this so called formulation is prescribed should be published . Just using I c m r has no relevance they approve any project it does not mean it is authentic . Why these ayurvedhachryas pick up self limiting diseases why not diseases like tuberculosis , enteric fever,and other bacterial diseases .thses ayurvedhacharyas are doing great disservice by picking up diseases which are not described in their system of medicine . Thses fellows are bluff masters . In fact there is nothing like alternative system of medicine ,shamelessly thses fellows are using knowledge of science and technology to propagate obscurantism and ignorence . Govts must think of controlling mosquito menace with the same money spent up on these fellows .

  5. user
    Murar Yeolekar May 21, 2018, 7:19 pm

    Given absence of specific drug against Dengue in modern medicine , the capsule with indigenous ingredients , when shown effective in trials , can fill in a huge gap in managing patients. All patients require supervision / observation and complicated ones may require intensive treatment. Best wishes to Prof Dhiman team ! Murar Yeolekar.Mumbai.

  6. user
    Dr Hasnain L PATEL May 21, 2018, 4:16 pm

    Jai Hind